Evaluation of Neutrophil to Lymphocyte Ratio in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma Treated With a Combination of Cetuximab and Nivolumab in a Phase II Clinical Trial. - Park R; Rind F; Kristoff T; Li J; Schell M; Slebos RJC; Thatikonda S; Chaudhary R; Biernacki MI; Meshkovska Y; Kaldas D; Kim HS; et al. (American journal of clinical oncology, 2026)